Relmada Therapeutics, Xenon Pharmaceuticals, Dianthus Therapeutics And Other Big Stocks Moving Higher On Monday
Avi Kapoor 7 months ago
US stocks tumble as Dow falls 650 points. Relmada Therapeutics stock rises 40.8% on promising cancer treatment data. Hims & Hers and Xenon Pharma jump over 40%.
U.S. stocks were lower, with the Dow Jones index falling around 650 points on Monday.
Shares of Relmada Therapeutics Inc (NASDAQ:RLMD) rose sharply during Monday's session following the release of promising interim data from its Phase 2 trial of NDV-01 for treating non-muscle invasive bladder cancer.
The 12-month interim data from the ongoing Phase 2 trial showed a complete response rate of 76%, with an impressive 80% in the BCG-unresponsive patient population.
Relmada Therapeutics shares jumped 40.8% to $6.27 on Monday.
Here are some other big stocks recording gains in today’s session.
- Hims & Hers Health Inc (NYSE:HIMS) shares jumped 42.6% to $22.44 after reports suggested that the company has agreed with Novo Nordisk to market weight-loss drugs from the Danish drugmaker on the Hims platform. Also, Novo Nordisk dropped its patent infringement case against the company.
- Xenon Pharmaceuticals Inc (NASDAQ:XENE) gained 42% to $59.53 following the announcement of positive topline results from the Phase 3 X-TOLE2 study of azetukalner in focal onset seizures.
- W&T Offshore, Inc. (NYSE:WTI) shares jumped 27.4% to $4.00.
- Dianthus Therapeutics Inc (NASDAQ:DNTH) gained 26.7% to $82.62 following an early GO decision announced by the company based on an interim responder analysis in the Phase 3 CAPTIVATE trial of claseprubart in chronic inflammatory demyelinating polyneuropathy (CIDP).
- Uniqure NV (NASDAQ:QURE) gained 21.1% to $17.28 after news that Dr. Vinay Prasad will step down from leading the U.S. Food and Drug Administration's biologics division.
- Solid Biosciences Inc (NASDAQ:SLDB) shares rose 20% to $8.10.
- Regenxbio Inc (NASDAQ:RGNX) shares jumped 18.7% to $10.26.
- Kingsoft Cloud Holdings Ltd (NASDAQ:KC) shares climbed 14.3% to $13.70.
- Garden Stage Ltd (NASDAQ:GSIW) shares climbed 10.2% to $10.51.
- Dyne Therapeutics Inc (NASDAQ:DYN) gained 10.2% to $16.37. Dyne Therapeutics said it initiated Phase 3 HARMONIA trial of Zeleciment Basivarsen (Z-basivarsen, DYNE-101) For Myotonic Dystrophy Type 1.
- Lumentum Holdings Inc (NASDAQ:LITE) gained 9.2% to $609.76.
- Circle Internet Group Inc (NYSE:CRCL) gained 8.7% to $110.80.
- United Therapeutics Corp (NASDAQ:UTHR) shares climbed 6.8% to $510.51. United Therapeutics announced a $2 billion stock repurchase authorization and enters into $1.5 billion accelerated share repurchase program.
- StubHub Holdings Inc (NYSE:STUB) gained 6.7% to $8.92.
- Denali Therapeutics Inc (NASDAQ:DNLI) shares surged 6.6% to $21.00.
Photo via Shutterstock